IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 33 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $28,000 | -6.7% | 48,399 | +64.4% | 0.00% | – |
| Q3 2021 | $30,000 | -11.8% | 29,447 | +1.2% | 0.00% | – |
| Q2 2021 | $34,000 | -35.8% | 29,106 | -29.0% | 0.00% | – |
| Q1 2021 | $53,000 | +140.9% | 41,000 | +304.1% | 0.00% | – |
| Q3 2020 | $22,000 | -90.7% | 10,147 | -88.5% | 0.00% | – |
| Q2 2019 | $237,000 | +507.7% | 88,608 | +522.0% | 0.00% | – |
| Q4 2018 | $39,000 | – | 14,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |